Schroder Investment Management Group Arcturus Therapeutics Holdings Inc. Transaction History

Schroder Investment Management Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $210,330 - $292,494	-6,150 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $171,462 - $358,237	6,150 New	6,150 $294,000
Q2 2021 Aug 13, 2021	SELL	$25.79 - $42.11 $826,801 - $1.35 Million	-32,059 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $2.15 Million - $4.82 Million	-55,466 Reduced 63.37%	32,059 $1.32 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $937,827 - $3.35 Million	27,097 Added 44.84%	87,525 $3.8 Million
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $2.27 Million - $3.82 Million	60,428 New	60,428 $2.59 Million

177

25.7M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $455M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.